Analysis of human pluripotent stem cell−derived cardiomyocytes using flow cytometry


MBTP 6 = Miltenyi Biotec-tested panel 6

This application protocol describes the analysis of pluripotent stem cell−derived cardiomyocytes. To demonstrate the state-of-the-art panel for stem cell cardiomyocyte differentiation, cardiomyocytes were generated from human pluripotent stem cells (PSCs).

Protocol

Antibody panel for pluripotent stem cell−derived cardiomyocytes

SpecificityClonePurposeFluorochromeDetection filter (nm) (laser)
Cardiac Troponin TREA400CardiomyocytesFITC525/50 (blue)
α-Actinin (Sarcomeric)REA402CardiomyocytesVioBlue®
450/50 (violet)
Myosin Heavy ChainREA399CardiomyocytesAPC655−730 (red)
MLC2aREA398Cardiomyocyte subtypeAPC655−730 (red)
MLC2vREA401Cardiomyocyte subtypePE585/40 (blue)

Gating strategy

Shop required products for this application protocol

4 products found

|

You have previously chosen International as your location.
What do you want to do?